PDE5A and benign prostatic hyperplasia: In addition, Vignozzi et al. performed immunohistochemical analysis of the patients undergoing surgical treatment for BPH, and reported the inhibitory effect of vardenafil, another PDE5 inhibitor, on prostatic inflammation by CD45 immunostaining [71].